Drug class
Cephalosporins - 5th Generation
Fifth-generation cephalosporins are an advanced class of broad-spectrum, parenteral beta-lactam bactericidal antibiotics. Read more about Cephalosporins - 5th Generation
5 drugs in this class 5 manufacturers
Drugs in Cephalosporins - 5th Generation
ZERBAXA (ceftolozane sulfate/tazobactam sodium)
ZEVTERA (ceftobiprole medocaril)
CEFTAROLINE FOSAMIL (ceftaroline fosamil acetate)
CEFTAROLINE FOSAMIL (ceftaroline fosamil acetate)
Fifth-generation cephalosporins are an advanced class of broad-spectrum, parenteral beta-lactam bactericidal antibiotics.
Like earlier generations, they inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), but they are distinguished by high-affinity binding to modified PBPs such as PBP2a, conferring unique activity against methicillin-resistant *Staphylococcus aureus* (MRSA) while maintaining coverage against common gram-negative pathogens.
Agents in this class, such as ceftaroline and ceftobiprole, are primarily indicated for the management of acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, and hospital-acquired lower respiratory tract infections caused by susceptible multidrug-resistant organisms.
-
picmonic.com
Fifth-generation cephalosporins are an advanced class of broad-spectrum, parenteral beta-lactam bactericidal antibiotics Like earlier generations, they inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), but they are distinguished by high-affinity binding to modified PBPs such as PBP2a, conferring unique activity against methicillin-resistant *Staphylococcus aureus* (MRSA) while maintaining coverage against common gram-negative pathogens
-
nih.gov
Fifth-generation cephalosporins are an advanced class of broad-spectrum, parenteral beta-lactam bactericidal antibiotics
-
scribd.com
Like earlier generations, they inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), but they are distinguished by high-affinity binding to modified PBPs such as PBP2a, conferring unique activity against methicillin-resistant *Staphylococcus aureus* (MRSA) while maintaining coverage against common gram-negative pathogens Agents in this class, such as ceftaroline and ceftobiprole, are primarily indicated for the management of acute bacterial skin and skin structu...
-
merckmanuals.com
Like earlier generations, they inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), but they are distinguished by high-affinity binding to modified PBPs such as PBP2a, conferring unique activity against methicillin-resistant *Staphylococcus aureus* (MRSA) while maintaining coverage against common gram-negative pathogens
-
picmonic.com
Agents in this class, such as ceftaroline and ceftobiprole, are primarily indicated for the management of acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, and hospital-acquired lower respiratory tract infections caused by susceptible multidrug-resistant organisms
-
nih.gov
Agents in this class, such as ceftaroline and ceftobiprole, are primarily indicated for the management of acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, and hospital-acquired lower respiratory tract infections caused by susceptible multidrug-resistant organisms
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.